Sickle Cell Anemia: Clinical Trials

3 trials for Sickle Cell Anemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 3

Follow Sickle Cell Anemia: new trials by email Literature Review of Sickle Cell Anemia trials Research Report on Sickle Cell Anemia

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Actigraphy Improvement With Voxelotor (ActIVe) Study
Voxelotor - Sickle Cell Disease, Sickle Cell Anemia
Phase 4CompletedPfizer252020-12-212023-11-21
Voxelotor Sickle Cell Exercise Study
Voxelotor - Sickle Cell Anemia
Phase 4CompletedElizabeth Yang, MD, PhD142020-09-212022-06-15
Risk Clinical Stratification of Sickle Cell Disease in Nigeria, Assessment of Efficacy/Safety of Hydroxyurea Treatment
hydroxyurea - Sickle Cell Disease, Sickle Cell Anemia
Phase 4CompletedLoyola University532014-12-012023-03-09

Narrower conditions

Anemia, Sickle Cell (3)

Broader conditions

Anemia (3)  ·  Anemia, Hemolytic (3)  ·  Anemia, Hemolytic, Congenital (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Genetic Diseases, Inborn (3)  ·  Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Hemoglobinopathies (3)

Interventions

voxelotor (2)  ·  Hydroxyurea (1)

Sponsors

Elizabeth Yang, MD, PhD (1)  ·  Loyola University (1)  ·  Pfizer (1)

Countries

United States (2)  ·  Nigeria (1)

Top investigators

Bamidele O Tayo, PhD (1)  ·  Elizabeth Yang, MD, PhD. (1)  ·  Kari Wheeler, BSN, RN (1)  ·  Lewis Hsu, MD (1)  ·  Richard S Cooper, MD (1)  ·  Titilola S Akingbola, MBBS, FWACP (1)  ·  Victor R Gordeuk, MD (1)  ·  Vivian Phan, MS (1)

Results publications

PMID 29756251, PMID 30663794, PMID 37247190